ANTHEMAnthem Biosciences Ltd.

    Anthem Biosciences Ltd: results and news

    Every Anthem Biosciences Ltd filing with the NSE and BSE that Blacklitt has written about, explained in plain words and linked to the filing, newest first: earnings.

    1 article · Contract research and manufacturing (CRDMO) and specialty ingredients · Latest 3 Nov 2026

    A teaching laboratory with rows of workbenches, sinks and microscopes

    ANTHEMAnthem Biosciences Ltd.

    Anthem Biosciences Q2 FY27 Results: Consolidated Net Profit ₹211 Crore on Total Income of ₹653 Crore

    Anthem Biosciences (NSE: ANTHEM) reported consolidated total income of ₹652.93 crore and net profit of ₹211.46 crore for the quarter ended 30 Sep 2026, it said in a filing on 03 Nov 2026. Standalone total income was ₹636.80 crore and standalone net profit ₹220.89 crore.

    • Earnings
    • Contract research and manufacturing (CRDMO) and specialty ingredients

    Blacklitt Research3 min read